Dr. Miller described the PML cases and subsequent suspension of the drug from marketing as “a great tragedy for the entire MS community. We certainly hope that after the dust has cleared, we will be able to find a way to safely bring this drug back to patients,” he said, but added, “that remains to be seen.”
The FDA's public health advisory regarding natalizumabcan be found at www.fda.gov/cder/drug/advisory/natalizumab.htmwww.elan.com